---
title: 'Associate Director, Regulatory Operations at Acadia Pharmaceuticals Inc.'
canonical: 'https://feeny.ai/job/associate-director-regulatory-operations-acadia-pharmaceuticals-inc-princeton-0psrbfgmrp11'
type: 'job'
last_seen: '2026-11-02'
---

# Associate Director, Regulatory Operations at Acadia Pharmaceuticals Inc.

- **Company:** Acadia Pharmaceuticals Inc.
- **Location:** Princeton, NJ / San Diego, CA / South San Francisco, CA
- **Compensation:** $146k–$183k
- **Posted:** 2026-10-20
- **Last confirmed live:** 2026-11-02
- **Apply:** https://acadia.com/en-us/careers/job-board/8895046002?gh_jid=8895046002

## Job description

## About Acadia Pharmaceuticals

Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference.

Please note that this position can be based in San Diego, CA, San Francisco, CA, or Princeton, NJ. Acadia's hybrid model requires this role to work in our office three days per week on average.

Position Summary

The Associate Director, Regulatory Operations provides leadership for global regulatory submissions, regulatory information management, document management, and related technology. This role leads regulatory submission planning and delivery for assigned development and marketed products, serves as a subject matter expert for electronic document management, publishing, and Regulatory Information Management systems. The Associate Director partners with Regulatory Affairs and other cross-functional stakeholders, including external service providers to maintain compliant, efficient, inspection-ready processes and systems. The position operates with a high degree of independence, resolves complex operational and technical issues, and drives continuous improvement through governance, metrics, data quality, automation, and emerging technology.

Primary Responsibilities

Regulatory Submission Operations

- Lead and oversee the planning, preparation, formatting, assembly, publishing, quality control, dispatch, and archiving of global regulatory submissions and correspondence
- Coordinate submission deliverables for applications and lifecycle activities, including INDs, CTAs, NDAs, MAAs, amendments, supplements, health authority responses, and briefing documents
- Provide tactical guidance to global regulatory teams, translate regulatory strategy into executable operational plans, and identify and mitigate submission risks
- Interpret and apply current electronic submission standards, health authority technical requirements, internal policies, and operating procedures
- Serve as a point of escalation for submission, publishing, document, process, and technology issues; drive timely resolution with internal teams, IT and vendors
- Maintain complete, traceable, accurate, and readily retrievable regulatory records to support inspection readiness

Regulatory Information and Document Management

- Provide business ownership and operational leadership for assigned RIM and electronic document management capabilities, including registrations, submissions, submission archives, document metadata, records lifecycle management, dictionaries, and user administration
- Lead and support system governance and administrative processes, including access management, user training and experience, issue management, configuration, change control, release management, validation documentation, and ongoing operational support
- Partner with stakeholders to gather and translate business requirements into scalable system and process solutions
- Ensure regulatory information, documents, and records are managed in accordance with applicable regulations, company procedures, and validated-system requirements

Technology, Validation, and Continuous Improvement

- Partner with Information Technology, Quality, other business owners, and vendors on system implementations, upgrades, integrations, validation, and operational support
- Support validation activities, including user needs, requirements, risk assessment, test planning, test script authoring and execution, defect resolution, and release readiness
- Evaluate evolving regulations, industry practices, system capabilities, artificial intelligence, automation, and emerging technologies; recommend and implement fit-for-purpose improvements and participate in industry forums and represent Acadia at relevant conferences/events
- Lead process optimization and system configuration initiatives that improve quality, compliance, efficiency, usability, and transparency
- Develop and maintain SOPs, work instructions, standards, templates, checklists, governance documents, and training materials

Business Partnership

- Act as a trusted Regulatory Operations advisor to global regulatory teams and cross-functional partners
- Lead cross-functional initiatives and taskforces; influence decisions and promote consistent global practices without relying on formal authority
- Oversee external vendors, consultants, and contractors, including scope, quality, timelines, performance, and budget responsibilities
- May oversee and develop junior personnel and project team members, as assigned
- Other responsibilities as assigned

Education/Experience/Skills

- Bachelor’s degree in scientific discipline or related field. An equivalent combination of relevant education and experience may be considered
- Targeting 8 years of regulatory operations experience within the pharmaceutical or biotech industry
- Must have strong expertise in the eCTD process, oversight of electronic document management systems, and publishing software and tools
- Must have technical expertise in EDMS oversight
- Thorough knowledge of US and international regulations as they apply to Regulatory Affairs Operations
- Ability to influence and partner cross-functionally
- Self-organized, self-directing, and highly motivated
- Strong critical thinking and analytical skills
- Demonstrated ability to contribute to a continuous learning and process improvement environment
- Excellent verbal and written organizational and communication skills
- Willingness and ability to travel domestically and internationally as needed

Physical Requirements

This role involves regular standing, walking, sitting, and the use of hands for handling or operating equipment. The employee may also need to reach, climb, balance, stoop, kneel, crouch, and maintain visual, verbal, and auditory communication in a standard office environment and while working independently from remote locations. The employee must occasionally lift and/or move up to 20 pounds.  This position requires the ability to travel independently overnight and/or work after hours as required by travel schedules or business needs.

## #LI-RE1 #LI-HYBRID

In addition to a competitive base salary, this position is also eligible for discretionary bonus and equity awards based on factors such as individual and organizational performance. Actual amounts will vary depending on experience, performance, and location.

Salary Range $146,000—$182,500 USD

What we offer US-based Employees:

- Competitive base, bonus, new hire and ongoing equity packages
- Medical, dental, and vision insurance
- Employer-paid life, disability, business travel and EAP coverage
- 401(k) Plan with a fully vested company match 1:1 up to 5%
- Employee Stock Purchase Plan with a 2-year purchase price lock-in
- 15+ vacation days
- 13 -15 paid holidays, including office closure between December 24th and January 1st
- 10 days of paid sick time
- Paid parental leave benefit
- Tuition assistance

EEO Statement (US-based Employees): Studies have shown that women and people of color are less likely to apply for jobs unless they believe they meet every one of the qualifications in the exact way they are described in job postings. We are committed to building a diverse, equitable, inclusive, and innovative company, and we are looking for the BEST candidate for the job. That candidate may be one who comes from a less traditional background or may meet the qualifications in a different way. We strongly encourage you to apply, especially if the reason you are the best candidate isn’t exactly what we describe here.

It is the policy of Acadia to provide equal employment opportunities to all employees and employment applicants without regard to considerations of race, including related to hairstyle, color, religion or religious creed, sexual orientation, gender, gender identity, gender expression, gender transition, country of origin, ancestry, citizenship, age, physical or mental disability, genetic information, legally-protected medical condition or information, marital status, domestic partner status, family care status, military caregiver status, veteran or military status (including reserve status, National Guard status, and military service or obligation), status as a victim of domestic violence, sexual assault or stalking, enrollment in a public assistance program, or any basis protected under federal, state or local law.

As an equal opportunity employer, Acadia is committed to a diverse workforce. If you are a qualified individual with a disability or a disabled veteran, you have the right to request a reasonable accommodation. Furthermore, you may request additional support if you are unable or limited in your ability to use or access Acadia’s career website due to your disability, along with any accommodations throughout the interview process. To request or inquire about your reasonable accommodation, please complete our [Reasonable Accommodation Request Form](https://app.smartsheet.com/b/form/43db301ada19415fa7ab365633993f33) or contact us at talentacquisition@acadia-pharm.com or 858-261-2923.

Please note that reasonable accommodations granted throughout the recruiting process are not guaranteed to be the same accommodations given if hired. A new request will need to be submitted for any ADA accommodations after starting employment.

California Applicants: Please see [Additional Information for California Residents](https://acadia.com/en-us/legal-policies/privacy#18) within our Privacy Policy.

Canadian Applicants: Please see [Additional Information for Canadian Residents](https://acadia.com/en-gb/legal-policies/privacy#17) within our Privacy Policy.

Applicants in the European Economic Area, Switzerland, the United Kingdom, and Serbia: Please see [Additional Information for Individuals in the European Economic Area, Switzerland, the United Kingdom, and Serbia](https://acadia.com/en-gb/legal-policies/privacy#16) within our Privacy Policy.

Notice to Search Firms/Third-Party Recruitment Agencies (Recruiters): The Talent Acquisition team manages the recruitment and employment process for Acadia Pharmaceuticals Inc. (“Acadia”). Acadia does not accept resumes from recruiters or search firms without an executed search agreement in place. Resumes sent to Acadia employees in the absence of an executed search agreement will not obligate Acadia in any way with respect to the future employment of those individuals or potential remuneration to any recruiter or search firm. Candidates should never be submitted directly to our hiring managers or employees.

## About Acadia Pharmaceuticals Inc.

## Company Overview
- **One-liner**: Acadia Pharmaceuticals is a biopharmaceutical company focused on turning scientific promise into meaningful innovation for underserved neurological and rare disease communities.
- **Entity Type**: Public (NASDAQ: ACAD)
- **Headquarters**: San Diego, California, USA (with additional offices in Princeton, NJ; Oakville, Canada; Zug and Basel, Switzerland; Amsterdam, Netherlands) [acadia.com](https://acadia.com/en-us/about)
- **Founded**: 1993 [acadia.com](https://acadia.com/en-us/about) (schema.org data)
- **Founders**: Not publicly available from provided sources

## Core Business
- **Primary industry**: Biopharmaceuticals – neurological disorders and rare diseases
- **Target customers**: Healthcare providers, patients, and caregivers dealing with Parkinson’s disease psychosis (PDP) and Rett syndrome; also developing therapies for Alzheimer’s disease psychosis, Lewy body dementia, major depressive disorder, essential tremor, and other conditions.
- **Mission/Purpose**: “Be Their Difference” – advancing brighter futures for those living with neurological disorders and rare diseases, guided by science and shaped by patient insight. [acadia.com](https://acadia.com/en-us/careers)

## Products & Services
- **NUPLAZID (pimavanserin)** – First and only FDA-approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). Commercial drug, small molecule. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **DAYBUE (trofinetide)** – First and only FDA-approved therapy for Rett syndrome. Commercial drug. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **DAYBUE STIX** – Powder formulation of trofinetide, approved in 2025 based on patient feedback, offering flexibility and portability. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **Remlifanserin (ACP-204)** – Late-stage pipeline candidate for Alzheimer’s disease psychosis (ADP) and Lewy body dementia psychosis (LBDP). Phase 2 studies initiated. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **ACP-211** – Phase 2 candidate for major depressive disorder (MDD). [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **ACP-711** – Early-stage candidate for essential tremor. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- Additional early-stage research programs in neurological and rare diseases.

## Market Standing
- **Valuation/Market Cap**: Not publicly available from provided sources. The company ended 2025 with $820 million in cash. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **Key Metric**: **$1.07 billion total revenue in 2025** (first time exceeding $1 billion). NUPLAZID net sales: $680 million (up 12% YoY); DAYBUE net sales: $391 million (up 12% YoY). [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
- **Notable Investors/Partners**: Not listed in provided sources. As a public company, institutional and retail shareholders.
- **Growth Signals**:
  - Surpassed $1B revenue milestone.
  - FDA approval of DAYBUE STIX (patient-informed formulation).
  - 40% of NUPLAZID prescribers in 2025 were new to the brand.
  - DAYBUE approved in U.S., Canada, Israel; named-patient programs in additional countries.
  - Initiated Phase 2 studies for remlifanserin (ADP, LBDP) and ACP-211 (MDD).
  - Combined peak sales opportunity for four key pipeline assets estimated at ~$11 billion.
  - Over 100,000 patients treated with NUPLAZID in U.S. since launch; ~1,000 active DAYBUE patients globally. [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)

## Competitive Advantages
- **First-to-market position** in two underserved indications: the only FDA-approved therapies for PDP (NUPLAZID) and Rett syndrome (DAYBUE).
- **Strong commercial portfolio** generating over $1B in annual revenue and growing.
- **Diverse pipeline** targeting large, high-unmet-need markets with differentiated mechanisms (e.g., Alzheimer’s disease psychosis, which has no approved therapy).
- **Patient-centric approach** (DAYBUE STIX developed from direct caregiver feedback) and deep expertise in neurology and rare diseases.
- **Global expansion** capabilities and established regulatory pathways in multiple regions.

## Strategic Focus
- **Accelerate growth** of NUPLAZID and DAYBUE in the U.S. by expanding prescriber base, improving diagnosis rates, and launching new formulations.
- **Advance global access** through regulatory approvals in new markets and named-patient programs.
- **Progress pipeline** toward late-stage trials, particularly remlifanserin for Alzheimer’s disease psychosis (Phase 2) and Lewy body dementia psychosis, as well as ACP-211 for MDD.
- **Build organizational capabilities** for scale: strengthened leadership team, operational excellence, and disciplined capital allocation (ended 2025 with $820M cash). [sec.gov Annual Report](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)

## Why Work Here
- **Culture & Purpose**: “Be Their Difference” – employees are driven by a mission to bring therapies to patients with few or no options. [acadia.com Careers](https://acadia.com/en-us/careers)
- **DEIB Commitment**: Diversity, Equity, Inclusion & Belonging is core to the work environment; diverse perspectives are cited as driving curiosity and innovation. [acadia.com DEIB](https://acadia.com/en-us/careers)
- **Total Rewards**: Competitive compensation, benefits, and programs designed to support employees and their families. [acadia.com Why Acadia](https://acadia.com/en-us/careers)
- **Work Flexibility**: Job listings indicate both **hybrid** and **remote** options available. [acadia.com Job Board](https://acadia.com/en-us/careers/job-board)
- **Growth Environment**: A company that went from ~$958M to >$1B revenue in one year, with a deep pipeline and global expansion – offering opportunity for career development in a high-impact therapeutic area.
- **Collaborative & Resourceful**: “Independent thinking and resourceful collaboration” highlighted as values; every role is seen as contributing to the mission. [acadia.com Job Board](https://acadia.com/en-us/careers/job-board)
- **Beware of recruitment scams**: The company notes that legitimate recruiters only use @acadia-pharm.com email domains and do not request personal info like SSN or payments. [acadia.com Job Board](https://acadia.com/en-us/careers/job-board)

## Sources
1. [acadia.com – About & Company Info](https://acadia.com/en-us/about)
2. [acadia.com – Careers Page](https://acadia.com/en-us/careers)
3. [acadia.com – Job Board / Current Openings](https://acadia.com/en-us/careers/job-board)
4. [SEC.gov – Acadia Pharmaceuticals 2025 Annual Report (10-K)](https://www.sec.gov/Archives/edgar/data/1070494/000119312526174167/acad_2025_annual_report.pdf)
5. [acadia.com – News Release: Q1 2026 Financial Results](https://acadia.com/en-us/media/news-releases/acadia-pharmaceuticals-reports-first-quarter-2) (referenced)

## Other roles at Acadia Pharmaceuticals Inc.

- [LTC Patient Access Manager - Northeast](https://feeny.ai/job/ltc-patient-access-manager-northeast-acadia-pharmaceuticals-inc-massachusetts-h0p2agyz5498) — Massachusetts / New Jersey / Pennsylvania / Rhode Island
- [Sr. Director, Regulatory Affairs, Technology & Transformation](https://feeny.ai/job/sr-director-regulatory-affairs-technology-transformation-acadia-pharmaceuticals-q5js4ccv30cv) — Princeton, NJ / San Diego, CA / South San Francisco, CA
- [Manager, Regulatory Affairs, Operations](https://feeny.ai/job/manager-regulatory-affairs-operations-acadia-pharmaceuticals-inc-princeton-kr6x5q8rv611) — Princeton, NJ / San Diego, CA / South San Francisco, CA
- [Sr. Manager Quality Audit and Compliance](https://feeny.ai/job/sr-manager-quality-audit-and-compliance-acadia-pharmaceuticals-inc-princeton-npt6dpn3atsd) — Princeton, NJ / San Diego, CA
- [Executive Director, People Business Partnership](https://feeny.ai/job/executive-director-people-business-partnership-acadia-pharmaceuticals-inc-cmq0hqe2geb6) — Princeton, NJ / San Diego, CA
- [Executive Director, People & Performance Technology & Operations](https://feeny.ai/job/executive-director-people-performance-technology-operations-acadia-anx50h526mtr) — Princeton, NJ / San Diego, CA
- [Area Business Manager - Dallas, TX](https://feeny.ai/job/area-business-manager-dallas-tx-acadia-pharmaceuticals-inc-texas-hfx7s0g2n0hw) — Texas
- [Neuroscience Regional Sales Manager - Pacific](https://feeny.ai/job/neuroscience-regional-sales-manager-pacific-acadia-pharmaceuticals-inc-south-zr1xrtzw2ynp) — South San Francisco, CA
- [Executive Neuroscience Sales Specialist - Richmond, VA](https://feeny.ai/job/executive-neuroscience-sales-specialist-richmond-va-acadia-pharmaceuticals-inc-gkprf5y5t0pb) — Virginia
- [Executive Long-Term Care Sales Specialist - Louisville, KY](https://feeny.ai/job/executive-long-term-care-sales-specialist-louisville-ky-acadia-pharmaceuticals-hnd5p2zkp5rc) — Indiana